Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hatteras Venture Partners is one of the leading early-stage venture capital firms focused on building transformational life science and healthcare companies in the United States. The firm has invested in over one hundred startups across biopharmaceuticals, medical devices, diagnostics, healthcare IT and related sectors. Its investment model leverages strong relationships with major academic centers such as UNC-Chapel Hill and Duke University to source innovative science-based opportunities. Notable exits include IPOs of Shattuck Labs and Kymera Therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hatteras Venture Partners.